SCHEMBL19628183

SCHEMBL19628183

CCOC(=O)c1ccccc1-c1cc2cccc3c(Br)cc4cccc1c4c23

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 8/20 0.51
CDC25A P30304 1/20 0.51
CDC25C P30307 1/20 0.51
TSHR P16473 1/20 0.47
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 1/20 0.43
USP2 O75604 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPK10 P53779 1/20 0.43
KMT2A Q03164 1/20 0.43
PTK2B Q14289 1/20 0.43
NCOA1 Q15788 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
GLA P06280 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16218426 0.89 CDC25B (0.57) CDC25BCDC25ACDC25CTSHRKDM4E
SCHEMBL15781501 0.88 CDC25B (0.53) CDC25BCDC25ACDC25CTSHRKDM4E
SCHEMBL13966911 0.81 TSHR (0.53) CDC25BCDC25ACDC25CTSHRKDM4E
SCHEMBL4072424 0.79 CDC25B (0.68) CDC25BCDC25ACDC25CTSHRKDM4E
SCHEMBL12731563 0.79 CDC25B (0.53) CDC25BCDC25ACDC25CTSHRKDM4E
SCHEMBL18428555 0.78 CDC25B (0.67) CDC25BCDC25ACDC25CTSHRKDM4E
SCHEMBL15985835 0.78 TSHR (0.51) CDC25BCDC25ACDC25CTSHRKDM4E
SCHEMBL28454296 0.77 TSHR (0.57) CDC25BCDC25ACDC25CTSHRKDM4E
SCHEMBL16153784 0.76 CDC25B (0.45) CDC25BCDC25ACDC25CTSHRKDM4E
SCHEMBL5096210 0.76 TSHR (0.65) CDC25BTSHRKDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) 2017-11-23 US disclosed
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 CDC25B 3336/4885CDC25A 3697/4885CDC25C 3763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.